{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:07:44Z","timestamp":1761844064034,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cjco.2024.08.008","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T06:39:29Z","timestamp":1724395169000},"page":"1355-1362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Centre-Specific Variation in Atrial Fibrillation Ablation-Treatment Rates in a Universal Single-Payer Healthcare System"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5733-1682","authenticated-orcid":false,"given":"Christina","family":"Seo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Angaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gozdyra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine S.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husam","family":"Abdel-Qadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dorian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C.Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2024.08.008_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2024.08.008_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamacardio.2021.0852","article-title":"Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation","volume":"6","author":"Turagam","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjco.2024.08.008_bib3","doi-asserted-by":"crossref","first-page":"e009692","DOI":"10.1161\/CIRCEP.120.009692","article-title":"Ablation versus antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation: a meta-analysis of randomized trials","volume":"14","author":"Kheiri","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjco.2024.08.008_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2024.08.008_bib5","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"Sohns","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2024.08.008_bib6","first-page":"1114","article-title":"2014 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"30","author":"Verma","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2024.08.008_bib7","first-page":"1170","article-title":"2016 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"32","author":"Macle","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2024.08.008_bib8","first-page":"1371","article-title":"2018 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"34","author":"Andrade","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2024.08.008_bib9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2024.08.008_bib10","first-page":"1847","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2024.08.008_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad074","article-title":"Variation and clinical consequences of wait-times for atrial fibrillation ablation: population level study in Ontario, Canada","volume":"25","author":"Qeska","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.cjco.2024.08.008_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12889-022-12628-9","article-title":"Socioeconomic and geographic differences in ablation of atrial fibrillation in Norway\u2014a national cohort study","volume":"22","author":"Olsen","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cjco.2024.08.008_bib13","doi-asserted-by":"crossref","first-page":"e210247","DOI":"10.1001\/jamanetworkopen.2021.0247","article-title":"Racial\/ethnic and socioeconomic disparities in management of incident paroxysmal atrial fibrillation","volume":"4","author":"Eberly","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjco.2024.08.008_bib14","first-page":"1335","article-title":"Who needs catheter ablation and which approach?","volume":"8","author":"Kocyigit","year":"2015","journal-title":"J\u00a0Atr Fibrillation"},{"key":"10.1016\/j.cjco.2024.08.008_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/europace\/eum144","article-title":"Gender-related differences in catheter ablation of atrial fibrillation","volume":"9","author":"Forleo","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.cjco.2024.08.008_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCULATIONAHA.122.058949","article-title":"Association of neighborhood-level material deprivation with atrial fibrillation care in a single-payer health care system: a population-based cohort study","volume":"146","author":"Abdel-Qadir","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2024.08.008_bib17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jacep.2016.09.003","article-title":"Factors associated with cardiac electrophysiologist assessment and catheter ablation procedures in patients with atrial fibrillation","volume":"3","author":"Singh","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjco.2024.08.008_bib18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.annemergmed.2013.06.005","article-title":"A\u00a0population-based description of atrial fibrillation in the emergency department, 2002 to 2010","volume":"62","author":"Atzema","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cjco.2024.08.008_bib19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2024.08.008_bib20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ahj.2015.03.006","article-title":"Geographic variation in the use of catheter ablation for atrial fibrillation among Medicare beneficiaries","volume":"169","author":"Sinner","year":"2015","journal-title":"Am Heart J"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X24003743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X24003743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:53:53Z","timestamp":1761843233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X24003743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2589790X24003743"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2024.08.008","relation":{},"ISSN":["2589-790X"],"issn-type":[{"type":"print","value":"2589-790X"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Centre-Specific Variation in Atrial Fibrillation Ablation-Treatment Rates in a Universal Single-Payer Healthcare System","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2024.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}